CRVS
Miller Richard A Md, CRVS's CEO, spent $60.3K of their own money on 5,000 shares at $12.
+$60.3K
5,000 sh @ $12
CRVS
Corvus Pharmaceuticals, Inc.
SEC CIK 1626971
$11.93
−42.7% · 90 days
90-day buys
$83.5K
2 open-market
90-day sells
$0
0 open-market
Net insider flow
+$83.5K
Net buying
Filings shown
66
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at CRVS have bought a net $83.5K of stock (2 open-market buys vs 0 sells).
Largest recent trade: Orbimed Advisors Llc sold $4.89M of CRVS, trimming their stake 14%.
Most active filer: Miller Richard A Md, with 38 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for CRVS, newest firstCRVS
Miller Richard A Md, CRVS's CEO, spent $23.2K of their own money on 1,932 shares at $12.
+$23.2K
1,932 sh @ $12
CRVS
+$450K
30,000 sh @ $15
CRVS
+$145.5K
15,000 sh @ $10
CRVS
+$187.5K
15,000 sh @ $13
Advertisement
CRVS
+$54.2K
15,000 sh @ $4
CRVS
+$30K
15,000 sh @ $2
CRVS
+$49.1K
15,000 sh @ $3
CRVS
+$41.1K
15,000 sh @ $3
CRVS
+$39K
15,000 sh @ $3
CRVS
+$14.8K
15,000 sh @ $1
CRVS
+$14.5K
15,000 sh @ $1
CRVS
+$37.4K
15,000 sh @ $2
CRVS
+$24.6K
15,000 sh @ $2
CRVS
+$31.8K
15,000 sh @ $2
CRVS
−$4.89M
1.18M sh @ $4
CRVS
−$4.89M
1.18M sh @ $4
CRVS
+$67.7K
19,357 sh @ $4
CRVS
+$1.96M
559,073 sh @ $4
CRVS
Jones William Benton, CRVS's See Remarks, spent $34.6K of their own money on 20,000 shares at $2, growing their stake 15%.
+$34.6K
20,000 sh @ $2
CRVS
Miller Richard A Md, CRVS's CEO, spent $1,000K of their own money on 577,634 shares at $2, opening a brand-new position.
+$1,000K
577,634 sh @ $2
CRVS
Grais Linda, CRVS's Director, spent $24.5K of their own money on 10,000 shares at $2, opening a brand-new position.
+$24.5K
10,000 sh @ $2
CRVS
Jones William Benton, CRVS's See Remarks, spent $15.8K of their own money on 20,000 shares at $1, growing their stake 18%.
+$15.8K
20,000 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $7.8K of their own money on 10,000 shares at $1, growing their stake 1%.
+$7.8K
10,000 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $37K of their own money on 50,000 shares at $1, growing their stake 3%.
+$37K
50,000 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $19.1K of their own money on 25,000 shares at $1, growing their stake 2%.
+$19.1K
25,000 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $10K of their own money on 12,300 shares at $1, growing their stake 1%.
+$10K
12,300 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $2.2K of their own money on 2,700 shares at $1.
+$2.2K
2,700 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $4.1K of their own money on 5,000 shares at $1.
+$4.1K
5,000 sh @ $1
CRVS
Miller Richard A Md, CRVS's CEO, spent $5K of their own money on 5,000 shares at $1.
+$5K
5,000 sh @ $1
Advertisement
About CRVS insider activity
This page tracks every recent Form 4 filed for Corvus Pharmaceuticals, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
What are the latest CRVS insider transactions?
The most recent Form 4 filings for CRVS are listed at the top of this page, newest first, usually within minutes of SEC acceptance. Each row shows the insider, transaction code, share count, and dollar value.
How often is CRVS insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Corvus Pharmaceuticals, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.